EUCTR2012-004063-52-IT进行中（未招募）1 期
ENALIDOMIDE MAINTENANCE IN MULTIPLE MYELOMA PATIENTS ACHIEVING AT LEAST VGPR AFTER INDUCTION THERAPY: MINIMAL RESIDUAL DISEASE MONITORING - MRD
FONDAZIONE NEOPLASIE SANGUE ONLUS0 个研究点目标入组 70 人开始时间: 2013年1月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Patient has achieved at least a Very Good Partial Response before starting maintenance treatment
- •- Availability of a bone marrow sample at diagnosed stored in the institution tissue bank to create patient-specific probes derived from IgH rearrangement
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
终止
2 期
Lenalidomide Maintenance Therapy for Multiple MyelomaMultiple MyelomaNCT01675141National Cancer Institute (NCI)11
进行中（未招募）
不适用
enalidomide maintenance therapy in patients with MDS or AML with cytogenetic abnormalities involving monosomy 5 or del5q after allogeneic hematopoietic stem cell transplantation (HSCT) - LENAMAINT TRIApatients with MDS or AML with cytogenetic abnormalities involving monosomy 5 or del5q after allogeneic hematopoietic stem cell transplantationEUCTR2007-002433-37-DETechnische Universität Dresden
已完成
3 期
Maintenance Therapy Using Lenalidomide in MyelomaMyelomaNCT00430365University Hospital, Toulouse614
已完成
不适用
Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD)Multiple MyelomaNCT03433365Fondazione EMN Italy Onlus70
进行中（未招募）
不适用
enalidomide for Myelodysplastic Syndromes: Efficacy, Safety, Cardiac Changes, and Quality of Life (QoL-ESC RevMDS) - QoL-ESC RevMDSow or Intermediate-1 IPSS risk MDS with del(5q)as a single or combined cytogenetic abnormality and with anemiaMedDRA version: 9.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersEUCTR2008-000547-34-ITASSOCIAZIONE QOL-ONE